首页> 外文期刊>Tumour biology : >TLR2 Delta 22 (-196-174) significantly increases the risk of breast cancer in females carrying proline allele at codon 72 of TP53 gene: a case-control study from four ethnic groups of North Eastern region of India
【24h】

TLR2 Delta 22 (-196-174) significantly increases the risk of breast cancer in females carrying proline allele at codon 72 of TP53 gene: a case-control study from four ethnic groups of North Eastern region of India

机译:TLR2 Delta 22(-196-174)大大增加了在TP53基因第72位密码子上携带脯氨酸等位基因的女性患乳腺癌的风险:一项来自印度东北地区四个种族的病例对照研究

获取原文
获取原文并翻译 | 示例
       

摘要

Breast cancer (BC) is the second most common cancer in women. In the North Eastern Region (NER) of India, BC is emerging as an important concern as evidenced by the data available from population and hospital-based cancer registries. Studies on genetic susceptibility to BC are important to understand the increase in the incidence of BC in NER. The present case control study was conducted to investigate the association between tumour suppressor gene TP53 codon 72 polymorphism and innate immune pathway gene TLR2a dagger 22 (-196-174) polymorphism with BC in females of NER of India for the identification of novel biomarker of BC. Four hundred sixty-two histopathologically confirmed BC cases from four states of NER of India, and 770 healthy controls were included by organizing community surveys from the neighbourhood of cases. In our study, no significant association between TP53 codon 72 polymorphisms and the risk of BC was found. However, our study has shown that TP53 codon 72 polymorphism is an important effect modifier. In the present study it was found that females carrying 22 base-pair deletion in the promoter region of their TLR2 gene had two times (AOR= 2.18, 95 % CI 1.13-4.21, p=0.019 in dominant model; AOR= 2.17, 95 % CI 1.09-4.34, p=0.027 in co-dominant model) increased risk of BC whwn they also carry proline allele at codon 72 of their TP53 gene.
机译:乳腺癌(BC)是女性中第二常见的癌症。在印度东北地区(NER),人口和医院癌症登记处提供的数据证明,卑诗省正在成为一个重要问题。对BC的遗传易感性研究对于了解NER中BC发病率的增加很重要。进行本病例对照研究以调查印度NER的女性中肿瘤抑制基因TP53密码子72多态性与先天免疫途径基因TLR2a匕首22(-196-174)多态性与BC之间的关联,以鉴定BC的新生物标记。 。通过组织来自社区的社区调查,纳入了来自印度NER四个州的462例经组织病理学证实的BC病例,并纳入了770名健康对照。在我们的研究中,未发现TP53密码子72多态性与BC风险之间存在显着关联。然而,我们的研究表明TP53密码子72多态性是一个重要的效应修饰因子。在本研究中,发现在其TLR2基因的启动子区域中携带22个碱基对缺失的雌性具有两次(AOR = 2.18,95%CI 1.13-4.21,p = 0.019;在显性模型中; AOR = 2.17,95 %CI 1.09-4.34,在共同主导模型中p = 0.027)增加了BC的风险,因为它们还在其TP53基因的密码子72处携带脯氨酸等位基因。

著录项

相似文献

  • 外文文献
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号